Advisors Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$453K Sell
856
-1,800
-68% -$831K 0.01% 1009
2026
Q1
$1.28M Sell
2,656
-548
-17% -$281K 0.02% 731
2025
Q4
$1.8M Sell
3,204
-3,301
-51% -$1.87M 0.03% 625
2025
Q3
$3.34M Sell
6,505
-466
-7% -$203K 0.06% 437
2025
Q2
$2.19M Sell
6,971
-174
-2% -$52.2K 0.04% 549
2025
Q1
$2.18M Sell
7,145
-50
-0.7% -$16.8K 0.04% 536
2024
Q4
$2.39M Buy
7,195
+1,046
+17% +$355K 0.04% 518
2024
Q3
$2.05M Buy
6,149
+854
+16% +$324K 0.04% 549
2024
Q2
$2.18M Buy
5,295
+2,560
+94% +$1.01M 0.04% 522
2024
Q1
$1.11M Buy
2,735
+1,410
+106% +$496K 0.02% 712
2023
Q4
$406K Buy
+1,325
New +$358K 0.01% 956
2021
Q4
Sell
-113
Closed -$21K 1507
2021
Q3
$21K Sell
113
-8
-7% -$1.46K ﹤0.01% 1455
2021
Q2
$21K Hold
121
﹤0.01% 1388
2021
Q1
$19.9K Sell
121
-3
-2% -$459 ﹤0.01% 1463
2020
Q4
$17K Sell
124
-5,369
-98% -$677K ﹤0.01% 1483
2020
Q3
$614K Sell
5,493
-9,141
-62% -$1.06M 0.01% 858
2020
Q2
$1.36M Sell
14,634
-115
-0.8% -$9.79K 0.03% 596
2020
Q1
$1.08M Sell
14,749
-683
-4% -$59.3K 0.03% 593
2019
Q4
$1.3M Sell
15,432
-429
-3% -$33.2K 0.02% 671
2019
Q3
$1.33M Sell
15,861
-692
-4% -$52.3K 0.02% 661
2019
Q2
$1.08M Sell
16,553
-456
-3% -$26.3K 0.02% 753
2019
Q1
$1M Buy
17,009
+3,611
+27% +$216K 0.02% 780
2018
Q4
$709K Buy
13,398
+8,090
+152% +$444K 0.01% 884
2018
Q3
$318K Buy
+5,308
New +$290K 0.01% 1150

Other funds holding MEDP

Advisors Asset Management's MEDP Position: Q2 2026 in Review

Advisors Asset Management reduced its Medpace (MEDP) stake by 68% in Q2 2026, selling an estimated $831K and leaving 856 shares worth $453K. The position accounts for 0.01% of the portfolio, ranked #1009.

Advisors Asset Management first reported a position in MEDP in Q3 2018 and has held it in 24 quarters since. The position peaked at $3.34M in Q3 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Advisors Asset Management held 856 shares of Medpace worth $453K as of Q2 2026.
  • Advisors Asset Management sold 1,800 Medpace shares in Q2 2026, an estimated $831K.
  • Medpace made up 0.01% of Advisors Asset Management's portfolio in Q2 2026, its #1009 holding.
  • Advisors Asset Management first reported a position in Medpace in Q3 2018 and has held it in 24 quarters since.
  • Advisors Asset Management's Medpace position peaked at $3.34M in Q3 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.